Heart disease, cancer and diabetes all cause weaker hand grip strength.
How a seaweed extract could help treat type 1 diabetes.
What makes us comply with the rules? Behavioural economics holds some clues for how to enforce coronavirus measures.
Let's not shut the debate down.
The Office for National Statistics reports the highest drug deaths since records began in 1993.
The UK government is set to introduce a three-tier system of lockdowns.
Control of an infectious disease through build-up of natural immunity has never been achieved before, and there's no reason to believe COVID-19 is any different.
These drugs may help slow or reverse immune system decline.
People aren't uniform in how they behave – nor in how they spread disease. At a population level, that makes a difference.
Governments need to engage not just with anti-vaxxers, but with concerns about the safety and environmental impact of vaccines
A new study finds a link between having young children at home and a lower risk of catching COVID-19.
Both Moderna and AstraZeneca have used cutting-edge designs to reduce their vaccines' development time.
Social media and changing ideas about masculinity are making more and more young men believe their body is too small, skinny or insufficiently muscular.
Protein is extremely important for our health as we age.
Epidemiologists reviewed 25 studies of cloth face masks. Here’s what they found out about how well they work, why they work, who they protect and why the mosquito and chain-link fence analogy is wrong.
There are any more sophisticated programs available for managing health data. Why did Public Health England use Microsoft Excel?
The swab test may be uncomfortable, but it is perfectly safe.
The test and trace fiasco shows what happens when a government demands certainty from an unpredictable virus.
Herd immunity has entered the everyday language, but it is a much misunderstood term.
Age, obesity and being male all increase the risk of COVID, but being wealthy is a protective factor.
